Oncolytics Biotech Inc. – Filings and Transcripts

NASDAQ: ONCY
Share price (7/7/26): $0.86
Market cap (7/7/26): $102 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Post-effective amendment

Post-effective amendment

Post-effective amendment

Post-effective amendment

Post-effective amendment

Ownership Filter

McAdory John Bearden

Glover Stephen C.

Brown Deborah Margaret

McAdory John Bearden

News Filter

Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep Into 2044

Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination With RAS-Targeted Approaches

Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness